Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment

키워드

참고문헌 (178)

1. Craiglow BG, "The close resemblance between patients with severe alopecia areata and those with cancer : what hair tells us about wellness or grave illness", J Am Acad Dermatol, 86, pp.e125~e126 (2022)
2. Meah N, "The Alopecia Areata Consensus of Experts(ACE)study : results of an international expert opinion on treatments for alopecia areata", J Am Acad Dermatol, 83, pp.123~130 (2020)
3. Meah N, "The Alopecia Areata Consensus of Experts(ACE)study part II : results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata", J Am Acad Dermatol, 84, pp.1594~1601 (2021)
4. Rossi A, "Italian Guidelines in diagnosis and treatment of alopecia areata", G Ital Dermatol Venereol, 154, pp.609~623 (2019)
5. Lai VWY, "Systemic treatments for alopecia areata : a systematic review", Australas J Dermatol, 60, pp.e1~e13 (2019)
6. Cranwell WC, "Treatment of alopecia areata : an Australian expert consensus statement", Australas J Dermatol, 60, pp.163~170 (2019)
7. Lee S, "Management of alopecia areata : updates and algorithmic approach", J Dermatol, 44, pp.1199~1211 (2017)
8. Messenger AG, "British Association of Dermatologists' guidelines for the management of alopecia areata 2012", Br J Dermatol, 166, pp.916~926 (2012)
9. MacDonald Hull SP, "Guidelines for the management of alopecia areata", Br J Dermatol, 149, pp.692~699 (2003)
10. Phillips B, "Oxford centre for evidence-based medicine-levels of evidence" (1998), University of Oxford
11. Devi M, "Intralesional triamcinolone acetonide versus topical betamethasone valearate in the management of localized alopecia areata", J Coll Physicians Surg Pak, 25, pp.860~862 (2015)
12. Kuldeep C, "Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata", Int J Trichology, 3, pp.20~24 (2011)
13. Suchonwanit P, "A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata", J Dermatolog Treat, 33, pp.756~761 (2022)
14. Yee BE, "Efficacy of different concentrations of intralesional triamcinolone acetonide for alopecia areata : a systematic review and meta-analysis", J Am Acad Dermatol, 82, pp.1018~1021 (2020)
15. Kaur S, "Comparative evaluation of intralesional triamcinolone acetonide injection, narrow band ultraviolet B, and their combination in alopecia areata", Int J Trichology, 7, pp.148~155 (2015)
16. Sanga ZN, "A study on efficacy of 308 nm excimer light therapy in alopecia areata", Przegl Dermatol, 102, pp.198~205 (2015)
17. Amirnia M, "Comparative study of intralesional steroid injection and cryotherapy in alopecia areata", Niger Med J, 56, pp.249~252 (2015)
18. Ustuner P, "Best dilution of the best corticosteroid for intralesional injection in the treatment of localized alopecia areata in adults", J Dermatolog Treat, 28, pp.753~761 (2017)
19. Waśkiel-Burnat A, "Therapeutic management in paediatric alopecia areata : a systematic review", J Eur Acad Dermatol Venereol, 35, pp.1299~1308 (2021)
20. Pascher F, "Assay of 0. 2 percent fluocinolone acetonide cream for alopecia areata and totalis. Efficacy and side effects including histologic study of the ensuing localized acneform response", Dermatologica, 141, pp.193~202 (1970)
21. Lenane P, "Clobetasol propionate, 0. 05%, vs hydrocortisone, 1%, for alopecia areata in children : a randomized clinical trial", JAMA Dermatol, 150, pp.47~50 (2014)
22. Jung KE, "Comparison of the topical FK506 and clobetasol propionate as first-line therapy in the treatment of early alopecia areata", Int J Dermatol, 56, pp.1487~1488 (2017)
23. Montes LF, "Topical halcinonide in alopecia areata and in alopecia totalis", J Cutan Pathol, 4, pp.47~50 (1977)
24. Tan E, "A clinical study of childhood alopecia areata in Singapore", Pediatr Dermatol, 19, pp.298~301 (2002)
25. Ucak H, "The comparison of treatment with clobetasol propionate 0. 05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata", J Dermatolog Treat, 23, pp.410~420 (2012)
26. Rigopoulos D, "Lack of response of alopecia areata to pimecrolimus cream", Clin Exp Dermatol, 32, pp.456~457 (2007)
27. Price VH, "Topical tacrolimus in alopecia areata", J Am Acad Dermatol, 52, pp.138~139 (2005)
28. Feldmann KA, "Is topical tacrolimus effective in alopecia areata universalis?", Br J Dermatol, 147, pp.1031~1032 (2002)
29. Thiers BH, "Topical tacrolimus : treatment failure in a patient with alopecia areata", Arch Dermatol, 136, pp.124~ (2000)
30. Barton VR, "Treatment of pediatric alopecia areata : a systematic review", J Am Acad Dermatol, 86, pp.1318~1334 (2022)
31. Sotiriou E, "Tacrolimus unguento 0, 1% nel trattamento dell’alopecia areata in chiazze in fase attiva del bambino", Eur J Pediat Dermatol, 17, pp.227~230 (2007)
32. Bimbi C, "Occlusive treatment enhances efficacy of tacrolimus 0. 1% in a pediatric patient with severe alopecia areata : case report and literature review", Pediatr Dermatol, 38, pp.339~340 (2021)
33. Molinelli E, "Efficacy and safety of topical calcipotriol 0.005% versus topical clobetasol 0.05% in the management of alopecia areata: an intrasubject pilot study", Dermatol Ther(Heidelb), 10, pp.515~521 (2020)
34. Çerman AA, "Topical calcipotriol therapy for mild-to-moderate alopecia areata : a retrospective study", J Drugs Dermatol, 14, pp.616~620 (2015)
35. Narang T, "Efficacy and safety of topical calcipotriol in management of alopecia areata : a pilot study", Dermatol Ther, 30, pp.e12464~ (2017)
36. Strazzulla LC, "Alopecia areata : an appraisal of new treatment approaches and overview of current therapies", J Am Acad Dermatol, 78, pp.15~24 (2018)
37. Stoehr JR, "Off-label use of topical minoxidil in alopecia : a review", Am J Clin Dermatol, 20, pp.237~250 (2019)
38. Fenton DA, "Topical minoxidil in the treatment of alopecia areata", Br Med J(Clin Res Ed), 287, pp.1015~1017 (1983)
39. Price VH, "Topical minoxidil(3%)in extensive alopecia areata, including long-term efficacy", J Am Acad Dermatol, 16(3 Pt 2), pp.737~744 (1987)
40. White SI, "Topical minoxidil lacks efficacy in alopecia areata", Arch Dermatol, 121, pp.591~ (1985)
41. Shapiro J, "Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5%minoxidil : a clinical and immunopathologic evaluation", J Am Acad Dermatol, 29(5 Pt 1), pp.729~735 (1993)
42. Fiedler-Weiss VC, "Topical minoxidil solution(1% and 5%)in the treatment of alopecia areata", J Am Acad Dermatol, 16(3 Pt 2), pp.745~748 (1987)
43. Khoury EL, "Topical minoxidil in alopecia areata : no effect on the perifollicular lymphoid infiltration", J Invest Dermatol, 99, pp.40~47 (1992)
44. Herskovitz I, "Minoxidil induced hypertrichosis in a 2 year-old child", F1000Res, 2, pp.226~ (2013)
45. Lenane P, "Congenital alopecia areata", J Am Acad Dermatol, 52(2 Suppl 1), pp.8~11 (2005)
46. Rai AK, "Minoxidil-induced hypertrichosis in a child with alopecia areata", Indian Dermatol Online J, 8, pp.147~148 (2017)
47. Guerouaz N, "Minoxidil induced hypertrichosis in children", Pan Afr Med J, 18, pp.8~ (2014)
48. Lim HS, "A case of generalized hypertrichosis after treatment with topical minoxidil", Korean J Dermatol, 39, pp.1420~1422 (2001)
49. Wang E, "Current treatment strategies in pediatric alopecia areata", Indian J Dermatol, 57, pp.459~465 (2012)
50. Tosti A, "Therapies versus placebo in the treatment of patchy alopecia areata", J Am Acad Dermatol, 15(2 Pt 1), pp.209~210 (1986)
51. Georgala S, "Topical use of minoxidil in children and systemic side effects", Dermatology, 214, pp.101~102 (2007)
52. Vila TO, "Bimatoprost in the treatment of eyelash universalis alopecia areata", Int J Trichology, 2, pp.86~88 (2010)
53. Coronel-Pérez IM, "Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis", J Eur Acad Dermatol Venereol, 24, pp.481~485 (2010)
54. Borchert M, "An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects", Clin Ophthalmol, 10, pp.419~429 (2016)
55. Yadav S, "An unusual anatomical colocalization of alopecia areata and vitiligo in a child, and improvement during treatment with topical prostaglandin E2", Clin Exp Dermatol, 34, pp.e1010~e1011 (2009)
56. Li AW, "Successful treatment of pediatric alopecia areata of the scalp using topical bimatoprost", Pediatr Dermatol, 33, pp.e282~e283 (2016)
57. Zaheri S, "Successful use of bimatoprost in the treatment of alopecia of the eyelashes", Clin Exp Dermatol, 35, pp.e161~e162 (2010)
58. Mehta JS, "Cutaneous latanoprost in the treatment of alopecia areata", Eye(Lond), 17, pp.444~446 (2003)
59. Ross EK, "Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata", J Am Acad Dermatol, 53, pp.1095~1096 (2005)
60. Faghihi G, "The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows", Eur J Dermatol, 19, pp.586~587 (2009)
61. Roseborough I, "Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata", J Am Acad Dermatol, 60, pp.705~706 (2009)
62. Aghaei S, "Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone(DPCP) : experience in an Iranian population", BMC Dermatol, 5, pp.6~ (2005)
63. Ajith C, "Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome", J Drugs Dermatol, 5, pp.262~266 (2006)
64. Ashworth J, "Allergic and irritant contact dermatitis compared in the treatment of alopecia totalis and universalis. A comparison of the value of topical diphencyprone and tretinoin gel", Br J Dermatol, 120, pp.397~401 (1989)
65. Avgerinou G, "Alopecia areata : topical immunotherapy treatment with diphencyprone", J Eur Acad Dermatol Venereol, 22, pp.320~323 (2008)
66. Case PC, "Topical therapy of alopecia areata with squaric acid dibutylester", J Am Acad Dermatol, 10, pp.447~450 (1984)
67. Caserio RJ, "Treatment of alopecia areata with squaric acid dibutylester", Arch Dermatol, 123, pp.1036~1041 (1987)
68. Chiang KS, "Clinical efficacy of diphenylcyclopropenone in alopecia areata : retrospective data analysis of 50 patients", J Investig Dermatol Symp Proc, 17, pp.50~55 (2015)
69. Cotellessa C, "The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata", J Am Acad Dermatol, 44, pp.73~76 (2001)
70. Dall'oglio F, "Topical immunomodulator therapy with squaric acid dibutylester(SADBE)is effective treatment for severe alopecia areata(AA) : results of an open-label, paired-comparison, clinical trial", J Dermatolog Treat, 16, pp.10~14 (2005)
71. Durdu M, "Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata : a retrospective case series", J Am Acad Dermatol, 72, pp.640~650 (2015)
72. El Khoury J, "Topical immunomodulation with diphenylcyclopropenone for alopecia areata : the Lebanese experience", Int J Dermatol, 52, pp.1551~1556 (2013)
73. El-Zawahry BM, "Five-year experience in the treatment of alopecia areata with DPC", J Eur Acad Dermatol Venereol, 24, pp.264~269 (2010)
74. Flowers FP, "Topical squaric acid dibutylester therapy for alopecia areata", Cutis, 30, pp.733~736 (1982)
75. Giannetti A, "Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester", Dermatologica, 167, pp.280~282 (1983)
76. Gordon PM, "Topical diphencyprone for alopecia areata : evaluation of 48 cases after 30 months'follow-up", Br J Dermatol, 134, pp.869~871 (1996)
77. Happle R, "Contact allergy as a therapeutic tool for alopecia areata : application of squaric acid dibutylester", Dermatologica, 161, pp.289~297 (1980)
78. Hatzis J, "Treatment of alopecia areata with diphencyprone", Australas J Dermatol, 29, pp.33~36 (1988)
79. Hoting E, "Therapy of alopecia areata with diphencyprone", Br J Dermatol, 127, pp.625~629 (1992)
80. Hull SM, "Diphencyprone in the treatment of long-standing alopecia areata", Br J Dermatol, 119, pp.367~374 (1988)
81. Hull SM, "Alopecia areata in children : response to treatment with diphencyprone", Br J Dermatol, 125, pp.164~168 (1991)
82. Hunter N, "Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers", J Dermatolog Treat, 22, pp.2~10 (2011)
83. Lamb RC, "Retrospective review of diphencyprone in the treatment of alopecia areata", Clin Exp Dermatol, 41, pp.352~358 (2016)
84. Losol E, "Squaric acid dibutyl ester for the treatment of alopecia areata : a retrospective evaluation", Dermatol Ther, 34, pp.e14726~ (2021)
85. Luk NM, "Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata", J Eur Acad Dermatol Venereol, 27, pp.e400~e405 (2013)
86. Micali G, "Treatment of alopecia areata with squaric acid dibutylester", Int J Dermatol, 35, pp.52~56 (1996)
87. Monk B, "Induction of hair growth in alopecia totalis with diphencyprone sensitization", Clin Exp Dermatol, 14, pp.154~157 (1989)
88. Nowicka D, "Efficacy of diphenylcyclopropenone in alopecia areata : a comparison of two treatment regimens", Postepy Dermatol Alergol, 35, pp.577~581 (2018)
89. Ohlmeier MC, "Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a selfcontrolled design", J Eur Acad Dermatol Venereol, 26, pp.503~507 (2012)
90. Orecchia G, "Topical immunotherapy in children with alopecia areata", J Invest Dermatol, 104(5 Suppl), pp.35~ (1995)
91. Orecchia G, "Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients", Pediatr Dermatol, 11, pp.65~68 (1994)
92. Pan R, "Chinese experience in the treatment of alopecia areata with diphenylcyclopropenone", J Dermatol, 42, pp.220~221 (2015)
93. Pardasani AG, "Squaric acid dibutylester : indications for use and efficacy in alopecia areata", Arch Dermatol, 137, pp.970~972 (2001)
94. Pericin M, "Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone : evaluation of 68 cases", Dermatology, 196, pp.418~421 (1998)
95. Salsberg JM, "The safety and efficacy of diphencyprone for the treatment of alopecia areata in children", Arch Dermatol, 148, pp.1084~1085 (2012)
96. Schuttelaar ML, "Alopecia areata in children : treatment with diphencyprone", Br J Dermatol, 135, pp.581~585 (1996)
97. Shapiro J, "Topical immunotherapy in the treatment of chronic severe alopecia areata", Dermatol Clin, 11, pp.611~617 (1993)
98. Sharma VK, "Topical immunotherapy with diphencyprone in Indians with alopecia areata", Clin Exp Dermatol, 23, pp.291~292 (1998)
99. Singh G, "Diphenylcyclopropenone immunotherapy in ophiasis", Indian J Dermatol Venereol Leprol, 73, pp.432~433 (2007)
100. Sotiriadis D, "Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata", Clin Exp Dermatol, 32, pp.48~51 (2007)
101. Tan E, "The pattern and profile of alopecia areata in Singapore--a study of 219 Asians", Int J Dermatol, 41, pp.748~753 (2002)
102. Thuangtong R, "Multi-concentration level patch test guided diphenyl cyclopropenone(DPCP)treatment in alopecia totalis or alopecia universalis", J Med Assoc Thai, 100, pp.86~92 (2017)
103. Tiwary AK, "Comparative study of efficacy and safety of topical squaric acid dibutylester and diphenylcyclopropenone for the treatment of alopecia areata", N Am J Med Sci, 8, pp.237~242 (2016)
104. Tosti A, "Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis", J Am Acad Dermatol, 35(2 Pt 1), pp.199~201 (1996)
105. Valsecchi R, "Topical immunotherapy of alopecia areata. A follow-up study", Acta Derm Venereol, 66, pp.269~272 (1986)
106. Valsecchi R, "Squaric acid dibutylester treatment of alopecia areata", Clin Exp Dermatol, 10, pp.233~238 (1985)
107. van Baar HM, "Dapsone versus topical immunotherapy in alopecia areata", Br J Dermatol, 133, pp.270~274 (1995)
108. van der Steen PH, "Topical immunotherapy for alopecia areata : re-evaluation of 139 cases after an additional follow-up period of 19 months", Dermatology, 184, pp.198~201 (1992)
109. van der Steen PH, "Treatment of alopecia areata with diphenylcyclopropenone", J Am Acad Dermatol, 24(2 Pt 1), pp.253~257 (1991)
110. Vedak P, "Squaric acid sensitization is not required for response in the treatment of alopecia areata", J Am Acad Dermatol, 73, pp.471~476 (2015)
111. Weise K, "Topical immunotherapy in alopecia areata : anamnestic and clinical criteria of prognostic significance", Dermatology, 192, pp.129~133 (1996)
112. Wiseman MC, "Predictive model for immunotherapy of alopecia areata with diphencyprone", Arch Dermatol, 137, pp.1063~1068 (2001)
113. Zerbinati N, "Topical immunotherapy of alopecia areata: a large retrospective study", Dermatol Ther(Heidelb), 8, pp.101~110 (2018)
114. Berth-Jones J, "Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone", Clin Exp Dermatol, 16, pp.172~175 (1991)
115. Hull SM, "Successful treatment of alopecia areata using the contact allergen diphencyprone", Br J Dermatol, 124, pp.212~213 (1991)
116. Iijima S, "Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester", Arch Dermatol, 133, pp.539~540 (1997)
117. Jang YH, "Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata", J Am Acad Dermatol, 77, pp.170~172 (2017)
118. Lee S, "Hair regrowth outcomes of contact immunotherapy for patients with alopecia areata : a systematic review and meta-analysis", JAMA Dermatol, 154, pp.1145~1151 (2018)
119. Gupta AK, "Monotherapy for alopecia areata : a systematic review and network meta-analysis", Skin Appendage Disord, 5, pp.331~337 (2019)
120. Choe SJ, "Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata : retrospective analysis of 159 cases", J Am Acad Dermatol, 78, pp.515~521 (2018)
121. Sriphojanart T, "A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata", Dermatol Reports, 9, pp.7399~ (2017)
122. Yoshimasu T, "Modified immunotherapy for alopecia areata", Autoimmun Rev, 15, pp.664~667 (2016)
123. Orecchia G, "Treatment of alopecia areata with diphencyprone", Dermatologica, 171, pp.193~196 (1985)
124. Das S, "Comparative assessment of topical steroids, topical tretenoin(0. 05%)and dithranol paste in alopecia areata", Indian J Dermatol, 55, pp.148~149 (2010)
125. Özdemir M, "Bilateral half-head comparison of 1% anthralin ointment in children with alopecia areata", Pediatr Dermatol, 34, pp.128~132 (2017)
126. Rocha VB, "Randomized controlled study comparing the use of diphencyprone and anthralin in the treatment of extensive chronic alopecia areata", An Bras Dermatol, 96, pp.372~376 (2021)
127. Nasimi M, "Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata : a retrospective case series", Arch Dermatol Res, 311, pp.607~613 (2019)
128. Bokhari L, "Treatment of alopecia universalis with topical Janus kinase inhibitors-a double blind, placebo, and active controlled pilot study", Int J Dermatol, 57, pp.1464~1470 (2018)
129. Olsen EA, "Ruxolitinib cream for the treatment of patients with alopecia areata : a 2-part, doubleblind, randomized, vehicle-controlled phase 2 study", J Am Acad Dermatol, 82, pp.412~419 (2020)
130. Putterman E, "Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis", J Am Acad Dermatol, 78, pp.1207~1209 (2018)
131. Lee JH, "Excimer laser", light treatment of alopecia areata : a systematic review and metaanalyses, 2020, pp.36, 460~469
132. Zakaria W, "308-nm excimer laser therapy in alopecia areata", J Am Acad Dermatol, 51, pp.837~838 (2004)
133. Al-Mutairi N, "308-nm excimer laser for the treatment of alopecia areata", Dermatol Surg, 33, pp.1483~1487 (2007)
134. Al-Mutairi N, "308-nm excimer laser for the treatment of alopecia areata in children", Pediatr Dermatol, 26, pp.547~550 (2009)
135. Byun JW, "Effectiveness of 308-nm excimer laser therapy in treating alopecia areata, determined by examining the treated sides of selected alopecic patches", Dermatology, 231, pp.70~76 (2015)
136. Aubin F, "Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology : a pilot study in different chronic localized dermatoses", Br J Dermatol, 152, pp.99~103 (2005)
137. Nisticò SP, "Different applications of monochromatic excimer light in skin diseases", Photomed Laser Surg, 27, pp.647~654 (2009)
138. Ohtsuki A, "308-nm excimer lamp for the treatment of alopecia areata : clinical trial on 16 cases", Indian J Dermatol, 58, pp.326~ (2013)
139. Arakawa Y, "Three hundred and eight nanometer excimer light therapy for alopecia universalis that is resistant to other treatments : a clinical study of 11 patients", J Dermatol, 43, pp.1412~1416 (2016)
140. Fenniche S, "Association of khellin and 308-nm excimer lamp in the treatment of severe alopecia areata in a child", J Cosmet Laser Ther, 20, pp.156~158 (2018)
141. Bayramgürler D, "Narrowband ultraviolet B phototherapy for alopecia areata", Photodermatol Photoimmunol Photomed, 27, pp.325~327 (2011)
142. El Taieb MA, "Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata : a randomized-controlled trial", Arch Dermatol Res, 311, pp.629~636 (2019)
143. Morsy H, "Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy", J Cosmet Dermatol, 17, pp.533~537 (2018)
144. Jury CS, "Narrowband ultraviolet B(UVB)phototherapy in children", Clin Exp Dermatol, 31, pp.196~199 (2006)
145. 전명수, "Therapeutic Effect of Superficial Cryotherapy on Alopecia Areata: A Prospective, Split-scalp Study in Patients with Multiple Alopecia Patches", Annals of Dermatology, 29(6), pp.722~727 (2017), 대한피부과학회
146. Zawar VP, "Liquid nitrogen cryotherapy in recalcitrant alopecia areata : a study of 11 patients", Int J Trichology, 8, pp.15~20 (2016)
147. Kim TH, "Effect of cryotherapy with liquid nitrogen on alopecia areata", Korean J Dermatol, 32, pp.421~426 (1994)
148. 이상주, "표재성 냉동요법으로 치료한 눈썹의 원형탈모증 2예", 대한피부과학회지, 41(8), pp.1079~1081 (2003), 대한피부과학회
149. 전수영, "표재성 냉동치료 요법으로 치료한 눈썹의 원형 탈모증 3예", 대한피부과학회지, 42(8), pp.1024~1027 (2004), 대한피부과학회
150. 홍승필, "원형탈모증에서 표재성 냉동치료 요법의 효과에 대한 후향적 고찰", 대한피부과학회지, 44(3), pp.274~280 (2006), 대한피부과학회
151. Faghihi G, "Jet cryotherapy vs clobetasol proprionate lotion in alopecia areata", Skinmed, 12, pp.209~211 (2014)
152. Choe SJ, "Efficacy of superficial cryotherapy on the eyebrows of patients with alopecia universalis also treated with contact immunotherapy on the scalp : a prospective, split-face comparative study", Int J Dermatol, 56, pp.184~189 (2017)
153. Jun M, "Efficacy and safety of superficial cryotherapy for alopecia areata: a retrospective, comprehensive review of 353 cases over 22 years", J Dermatol, 44, pp.386~393 (2017)
154. Abdel Motaleb AA, "Different freezing time of superficial liquid nitrogen cryotherapy in treatment of recalcitrant alopecia areata : randomized clinical trial", Dermatol Ther, 33, pp.e13640~ (2020)
155. Lee YB, "Efficacy of antihistamines in combination with topical corticosteroid and superficial cryotherapy for treatment of alopecia areata : a retrospective cohort study", J Am Acad Dermatol, 84, pp.1152~1154 (2021)
156. Chandrashekar B, "Alopecia areata-successful outcome with microneedling and triamcinolone acetonide", J Cutan Aesthet Surg, 7, pp.63~64 (2014)
157. Asad U, "Ophiasis alopecia areata treated with microneedling", Proc(Bayl Univ Med Cent), 33, pp.413~414 (2020)
158. Barletta M, "Successful treatment of alopecia areata patches with triamcinolone acetonide using MMP® : report of 2cases", Skin Appendage Disord, 6, pp.229~234 (2020)
159. Strazzulla LC, "An overview of the biology of platelet-rich plasma and microneedling as potential treatments for alopecia areata", J Investig Dermatol Symp Proc, 19, pp.S21~S24 (2018)
160. Ragab SEM, "Platelet-rich plasma in alopecia areata : intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling", Acta Dermatovenerol Alp Pannonica Adriat, 29, pp.169~173 (2020)
161. Yoo KH, "Photodynamic therapy with methyl 5-aminolevulinate acid might be ineffective in recalcitrant alopecia totalis regardless of using a microneedle roller to increase skin penetration", Dermatol Surg, 36, pp.618~622 (2010)
162. Giorgio CM, "Combination of photodynamic therapy with 5-aminolaevulinic acid and microneedling in the treatment of alopecia areata resistant to conventional therapies : our experience with 41 patients", Clin Exp Dermatol, 45, pp.323~326 (2020)
163. Trink A, "A randomized, double-blind, placebo-and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata", Br J Dermatol, 169, pp.690~694 (2013)
164. El Taieb MA, "Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata : a trichoscopic evaluation", Dermatol Ther, 30, pp.e12437~ (2017)
165. Balakrishnan A, "A comparative study of therapeutic response to intralesional injections of platelet-rich plasma versus triamcinolone acetonide in alopecia areata", Indian Dermatol Online J, 11, pp.920~924 (2020)
166. Kapoor P, "Comparative evaluation of therapeutic efficacy of intralesional injection of triamcinolone acetonide versus intralesional autologous plateletrich plasma injection in alopecia areata", J Cutan Aesthet Surg, 13, pp.103~111 (2020)
167. Hegde P, "A randomized, placebo and active controlled, split scalp study to evaluate the efficacy of plateletrich plasma in patchy alopecia areata of the scalp", Dermatol Ther, 33, pp.e14388~ (2020)
168. Li Y, "Hair regrowth in alopecia areata patients following Stem Cell Educator therapy", BMC Med, 13, pp.87~ (2015)
169. Elmaadawi IH, "Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia", J Dermatolog Treat, 29, pp.431~440 (2018)
170. Anderi R, "Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata", Stem Cell Res Ther, 9, pp.141~ (2018)
171. Ahn H, "Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells : three case reports and review of literature", World J Clin Cases, 9, pp.3741~3751 (2021)
172. Mendieta-Eckert M, "Treatment of patchy and universalis alopecia areata with fractional laser", Dermatol Surg, 46, pp.430~433 (2020)
173. Al-Dhalimi MA, "The use of a 1, 540 nm fractional erbium-glass laser in treatment of alopecia areata", Lasers Surg Med, 51, pp.859~865 (2019)
174. Waiz M, "Use of the pulsed infrared diode laser(904 nm)in the treatment of alopecia areata", J Cosmet Laser Ther, 8, pp.27~30 (2006)
175. Rencz F, "Alopecia areata and health-related quality of life : a systematic review and meta-analysis", Br J Dermatol, 175, pp.561~571 (2016)
176. 박진, "Role of Hair Prostheses (Wigs) in Patients with Severe Alopecia Areata", Annals of Dermatology, 30(4), pp.505~507 (2018), 대한피부과학회
177. Tosti A, "Alopecia areata : a long term followup study of 191 patients", J Am Acad Dermatol, 55, pp.438~441 (2006)
178. Ikeda T, "A new classification of alopecia areata", Dermatologica, 131, pp.421~445 (1965)

관련 논문AI추천